Kymera Therapeutics Inc (KYMR)
Stock-Based Compensation
$65.20M
TTM · Period ending: · USD
KYMR Stock-Based Compensation
Latest reported$65.20Mperiod ending
Latest reported$65.20Mperiod ending
KYMR TTM Stock-Based Comp ($5.19M → $65.20M)
TTM stock-based compensation
High-resolution chart · PNG
KYMR stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 65,200,000 | |
| 61,678,000 | |
| 59,904,000 | |
| 59,250,000 | |
| 58,352,000 | |
| 57,277,000 | |
| 55,012,000 | |
| 52,111,000 | |
| 48,862,000 | |
| 45,702,000 | |
| 43,119,000 | |
| 41,130,000 | |
| 38,551,000 | |
| 36,992,000 | |
| 35,480,000 | |
| 35,249,000 | |
| 33,569,000 | |
| 29,673,000 | |
| 24,972,000 | |
| 18,121,000 | |
| 13,053,000 | |
| 7,991,000 | |
| 5,190,000 | |
| 3,660,000 | |
| 1,566,000 |